Takahashi Y, Hayashi M, Kato T, Horikawa Y, et al. BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exerc Diabetes Obes Metab 2026 Jan 21. doi: 10.1111/dom.70494.
PMID: 41560588